Patent details
92826 Product Name: Lubiprostone, incluant les sels pharmaceutiquement acceptables, les esters ou les amides de la Lubiprostone
Basic Information
- Publication number:
- 92826
- Type:
- SPC
- SPC Type:
- Medical
- Basic Patent Number:
- EP100102110
- Legal Status:
- Invalid
- Application number:
- 92826
- First applicant's nationality:
- Procedural language:
- French
Marketing Authorization
1
- Marketing Authorization Number:
- 2015040035
- Marketing Authorization Type:
- Marketing Authorization Date:
- 01/04/2015
- Marketing Authorization Status:
- Accepted
- Marketing Authorization Country:
- Luxembourg (LU)
2
- Marketing Authorization Number:
- PL 21341/0003
- Marketing Authorization Type:
- Marketing Authorization Date:
- 10/09/2012
- Marketing Authorization Status:
- Accepted
- Marketing Authorization Country:
- United Kingdom (GB)
Dates
- Filing date:
- 11/09/2015
- First Marketing Authorization date:
- 10/09/2012
- Grant date:
- 24/11/2015
- Activation date:
- Publication date:
- 24/11/2015
- Lapsed date:
- Expiration date:
- Renunciation date:
- Revocation date:
- Annulment date:
- Basic SPC Expiration:
- 14/11/2027
- SPC Extension Expiration:
- 14/11/2027
- Rejection date:
- Withdrawal date:
Owner
- From:
- 11/09/2015
- Name:
- SUCAMPO AG
- Address:
- BAARERSTRASSE 22, 6300, ZUG, Switzerland (CH)
Agent
- Name:
- DENNEMEYER & ASSOCIATES S.A. PATENT DEPARTMENT
- From:
- 11/09/2015
- Address:
- PO Box 1502, 1015, LUXEMBOURG, Luxembourg (LU)
- To:
Inventor
1
- Name:
- Patchen Myra L.
- Address:
- United States (US)
2
- Name:
- Ueno Ryuji
- Address:
- United States (US)
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|